Detalles de la búsqueda
1.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883053
2.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34370971
3.
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants.
BMC Med
; 19(1): 138, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098951
4.
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Clin Infect Dis
; 61(11): 1637-44, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374816
5.
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial.
Lancet Microbe
; 4(5): e300-e308, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080224
6.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Lancet Infect Dis
; 21(5): 688-696, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428870
7.
Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.
Pediatrics
; 138(1)2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27255149
8.
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.
Pediatr Infect Dis J
; 34(8): 865-74, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26075813
9.
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.
Vaccine
; 33(5): 648-55, 2015 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25510388
10.
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.
Pediatr Infect Dis J
; 31(6): 616-22, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22333698
11.
Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men.
Am J Clin Nutr
; 95(6): 1461-7, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22572643
12.
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.
Clin Vaccine Immunol
; 18(3): 367-72, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21191076
13.
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
Clin Vaccine Immunol
; 17(1): 154-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19906895
Resultados
1 -
13
de 13
1
Próxima >
>>